Symmetry Medical, Inc. (SMA) Tops Q2 EPS by 2c, Lowers FY11 EPS and Revenue Guidance
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Price: $34.17 +1.36%
Financial Fact:
Operating Income: 3.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating Income: 3.06M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q2 adjusted EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $94.72 million versus the consensus estimate of $96.06 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.43-$0.57, versus prior guidance of $0.54-$0.65 and the consensus of $0.57. Symmetry Medical, Inc. sees FY2011 revenue of $354-$370 million, versus prior guidance of $363-$383 million and the consensus of $376.91 million.
Symmetry Medical, Inc. sees FY2011 EPS of $0.43-$0.57, versus prior guidance of $0.54-$0.65 and the consensus of $0.57. Symmetry Medical, Inc. sees FY2011 revenue of $354-$370 million, versus prior guidance of $363-$383 million and the consensus of $376.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
